-
1
-
-
37849041229
-
2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Antman E.M., Hand M., and Armstrong P.W. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 210-247
-
-
Antman, E.M.1
Hand, M.2
Armstrong, P.W.3
-
2
-
-
34247854930
-
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
-
Fox K.A., Steg P.G., and Eagle K.A. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
-
(2007)
JAMA
, vol.297
, pp. 1892-1900
-
-
Fox, K.A.1
Steg, P.G.2
Eagle, K.A.3
-
3
-
-
0025266820
-
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
-
Pfeffer M., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
-
(1990)
Circulation
, vol.81
, pp. 1161-1172
-
-
Pfeffer, M.1
Braunwald, E.2
-
4
-
-
31144476692
-
Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention
-
Biagini E., van Geuns R.J., and Baks T. Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention Am J Cardiol 97 2006 361 366
-
(2006)
Am J Cardiol
, vol.97
, pp. 361-366
-
-
Biagini, E.1
Van Geuns, R.J.2
Baks, T.3
-
5
-
-
51549089000
-
Prognostic implications of left ventricular mass and geometry following myocardial infarction: The VALIANT (VALsartan in Acute myocardial iNfarcTion) Echocardiographic Study
-
Verma A., Meris A., and Skali H. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study JACC Cardiovasc Imaging 1 2008 582 591
-
(2008)
JACC Cardiovasc Imaging
, vol.1
, pp. 582-591
-
-
Verma, A.1
Meris, A.2
Skali, H.3
-
6
-
-
33845981823
-
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention
-
The APEX Investigators Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention A randomized controlled trial. JAMA 297 2007 43 51
-
(2007)
A Randomized Controlled Trial. JAMA
, vol.297
, pp. 43-51
-
-
-
7
-
-
0035808003
-
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study
-
Baran K.W., Nguyen M., and McKendall G.R. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study Circulation 104 2001 2778 2783
-
(2001)
Circulation
, vol.104
, pp. 2778-2783
-
-
Baran, K.W.1
Nguyen, M.2
McKendall, G.R.3
-
8
-
-
0037010009
-
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of the HALT-MI study
-
Faxon D.P., Gibbons R.J., and Chronos N.A. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J Am Coll Cardiol 40 2002 1199 1204
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1199-1204
-
-
Faxon, D.P.1
Gibbons, R.J.2
Chronos, N.A.3
-
9
-
-
6344225691
-
Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury
-
Wright G.L., Hanlon P., and Amin K. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB 18 2004 1031 1033
-
(2004)
FASEB
, vol.18
, pp. 1031-1033
-
-
Wright, G.L.1
Hanlon, P.2
Amin, K.3
-
10
-
-
0038163900
-
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury
-
Cai Z., Manalo D.J., and Wei G. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79 85
-
(2003)
Circulation
, vol.108
, pp. 79-85
-
-
Cai, Z.1
Manalo, D.J.2
Wei, G.3
-
11
-
-
85047691007
-
A novel protective effect of erythropoietin in the infarcted heart
-
Parsa C.J., Matsumoto A., and Kim J. A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999 1007
-
(2003)
J Clin Invest
, vol.112
, pp. 999-1007
-
-
Parsa, C.J.1
Matsumoto, A.2
Kim, J.3
-
12
-
-
0141593556
-
Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats
-
Moon C., Krawczyk M., and Ahn D. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats Proc Natl Acad Sci U S A 100 2003 11612 11617
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 11612-11617
-
-
Moon, C.1
Krawczyk, M.2
Ahn, D.3
-
13
-
-
33845225092
-
Protective effects of erythropoietin in cardiac ischemia: From bench to bedside
-
Lipšic E., Schoemaker R.G., and van der Meer P. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside J Am Coll Cardiol 48 2006 2161 2167
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2161-2167
-
-
Lipšic, E.1
Schoemaker, R.G.2
Van Der Meer, P.3
-
14
-
-
21344459065
-
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction
-
van der Meer P., Lipšic E., and Henning R.H. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction J Am Coll Cardiol 46 2005 125 133
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 125-133
-
-
Van Der Meer, P.1
Lipšic, E.2
Henning, R.H.3
-
15
-
-
37549020370
-
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit
-
Lipšic E., Westenbrink B.D., and van der Meer P. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit Eur J Heart Fail 10 2008 22 29
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 22-29
-
-
Lipšic, E.1
Westenbrink, B.D.2
Van Der Meer, P.3
-
16
-
-
33745250458
-
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs
-
Hirata A., Minamino T., and Asanuma H. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs J Am Coll Cardiol 48 2006 176 184
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 176-184
-
-
Hirata, A.1
Minamino, T.2
Asanuma, H.3
-
17
-
-
0037458127
-
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure
-
Mancini D.M., Katz S.D., and Lang C.C. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure Circulation 107 2003 294 299
-
(2003)
Circulation
, vol.107
, pp. 294-299
-
-
Mancini, D.M.1
Katz, S.D.2
Lang, C.C.3
-
18
-
-
0036705708
-
Erythropoietin therapy for acute stroke is both safe and beneficial
-
Ehrenreich H., Hasselblatt M., and Dembowski C. Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 2002 495 505
-
(2002)
Mol Med
, vol.8
, pp. 495-505
-
-
Ehrenreich, H.1
Hasselblatt, M.2
Dembowski, C.3
-
19
-
-
57549083429
-
Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; Results from a pilot study
-
Liem A., van de Woestijne A.P., and Bruijns E. Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study Int J Cardiol 131 2009 285 287
-
(2009)
Int J Cardiol
, vol.131
, pp. 285-287
-
-
Liem, A.1
Van De Woestijne, A.P.2
Bruijns, E.3
-
20
-
-
70949095435
-
Recombinant human erythropoietin in the treatment of acute ischemic stroke
-
Ehrenreich H., Weissenborn K., and Prange H. Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 2009 e647 56
-
(2009)
Stroke
, vol.40
, pp. 647-656
-
-
Ehrenreich, H.1
Weissenborn, K.2
Prange, H.3
-
21
-
-
41049115024
-
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia
-
Ghali J.K., Anand I.S., and Abraham W.T. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia Circulation 117 2008 526 535
-
(2008)
Circulation
, vol.117
, pp. 526-535
-
-
Ghali, J.K.1
Anand, I.S.2
Abraham, W.T.3
-
22
-
-
78349287458
-
Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized, double-blind trial
-
Ott I., Schulz S., and Mehilli J. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial Circ Cardiovasc Interv 2010 [Epub ahead of print]. DOI: 10.1161/CIRCINTERVENTIONS.109.904425
-
(2010)
Circ Cardiovasc Interv
-
-
Ott, I.1
Schulz, S.2
Mehilli, J.3
-
23
-
-
40149083005
-
Performance of delayed-enhancement MRI using gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial
-
Kim R.J., Albert T.S., and Wible J.H. Performance of delayed-enhancement MRI using gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial Circulation 117 2008 629 637
-
(2008)
Circulation
, vol.117
, pp. 629-637
-
-
Kim, R.J.1
Albert, T.S.2
Wible, J.H.3
-
24
-
-
73649092447
-
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary PCI: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial
-
Patel M.R., Worthley S.G., and Stebbins A. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary PCI: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial JACC Cardiovasc Imaging 3 2010 52 60
-
(2010)
JACC Cardiovasc Imaging
, vol.3
, pp. 52-60
-
-
Patel, M.R.1
Worthley, S.G.2
Stebbins, A.3
-
25
-
-
58649089789
-
Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations
-
Povsic T.J., Zavodni K.L., and Vainorius E. Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations Am Heart J 157 2009 335 344
-
(2009)
Am Heart J
, vol.157
, pp. 335-344
-
-
Povsic, T.J.1
Zavodni, K.L.2
Vainorius, E.3
-
26
-
-
70349092726
-
Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples
-
Povsic T.J., Adams S.D., and Zavodni K.L. Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples J Thromb Thrombolysis 28 2009 259 265
-
(2009)
J Thromb Thrombolysis
, vol.28
, pp. 259-265
-
-
Povsic, T.J.1
Adams, S.D.2
Zavodni, K.L.3
-
27
-
-
34247558672
-
Clinical end points in coronary stent trials: A case for standardized definitions
-
Cutlip D.E., Windecker S., and Mehran R. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
-
(2007)
Circulation
, vol.115
, pp. 2344-2351
-
-
Cutlip, D.E.1
Windecker, S.2
Mehran, R.3
-
28
-
-
56349124221
-
Erythropoietin in heart and vessels: Focus on transcription and signalling pathways
-
Marzo F., Lavorgna A., and Coluzzi G. Erythropoietin in heart and vessels: focus on transcription and signalling pathways J Thromb Thrombolysis 26 2008 183 187
-
(2008)
J Thromb Thrombolysis
, vol.26
, pp. 183-187
-
-
Marzo, F.1
Lavorgna, A.2
Coluzzi, G.3
-
29
-
-
0028260228
-
Erythropoietin receptor mRNA expression in human endothelial cells
-
Anagnostou A., Liu Z., and Steiner M. Erythropoietin receptor mRNA expression in human endothelial cells Proc Natl Acad Sci U S A 91 1994 3974 3978 (Pubitemid 24139555)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.9
, pp. 3974-3978
-
-
Anagnostou, A.1
Liu, Z.2
Steiner, M.3
Chin, K.4
Lee, E.S.5
Kessimian, N.6
Noguchi, C.T.7
-
30
-
-
0042738942
-
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
-
Heeschen C., Aicher A., and Lehmann R. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization Blood 102 2003 1340 1346
-
(2003)
Blood
, vol.102
, pp. 1340-1346
-
-
Heeschen, C.1
Aicher, A.2
Lehmann, R.3
-
31
-
-
9144258353
-
Erythropoietin regulates endothelial progenitor cells
-
Bahlmann F.H., De Groot K., and Spandau J.M. Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
-
(2004)
Blood
, vol.103
, pp. 921-926
-
-
Bahlmann, F.H.1
De Groot, K.2
Spandau, J.M.3
-
32
-
-
0032945433
-
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
-
DOI 10.1038/7434
-
Takahashi T., Kalka C., and Masuda H. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat Med 5 1999 434 438 (Pubitemid 29180584)
-
(1999)
Nature Medicine
, vol.5
, Issue.4
, pp. 434-438
-
-
Takahashi, T.1
Kalka, C.2
Masuda, H.3
Chen, D.4
Silver, M.5
Kearney, M.6
Magner, M.7
Isner, J.M.8
Asahara, T.9
-
33
-
-
33745395054
-
Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia
-
Urao N., Okigaki M., and Yamada H. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia Circ Res 98 2006 1405 1413
-
(2006)
Circ Res
, vol.98
, pp. 1405-1413
-
-
Urao, N.1
Okigaki, M.2
Yamada, H.3
-
34
-
-
0025297296
-
Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells
-
Anagnostou A., Lee E.S., and Kessimian N. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells Proc Natl Acad Sci U S A 87 1990 5978 5982
-
(1990)
Proc Natl Acad Sci U S A
, vol.87
, pp. 5978-5982
-
-
Anagnostou, A.1
Lee, E.S.2
Kessimian, N.3
-
35
-
-
0035894847
-
Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells
-
Shingo T., Sorokan S.T., and Shimazaki T. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells J Neurosci 21 2001 9733 9743
-
(2001)
J Neurosci
, vol.21
, pp. 9733-9743
-
-
Shingo, T.1
Sorokan, S.T.2
Shimazaki, T.3
-
36
-
-
70350523713
-
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook and Dose Association Study (EPAMINONDAS)
-
Andreotti F., Agati L., and Conti E. Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS) J Thromb Thrombolysis 28 2009 48995 (EudraCTno. 200500485386)
-
(2009)
J Thromb Thrombolysis
, vol.28
, pp. 48995
-
-
Andreotti, F.1
Agati, L.2
Conti, E.3
-
38
-
-
3142598688
-
An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection
-
Bogoyevitch M.A. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection Cardiovasc Res 63 2004 208 216
-
(2004)
Cardiovasc Res
, vol.63
, pp. 208-216
-
-
Bogoyevitch, M.A.1
-
39
-
-
6944237300
-
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor
-
Brines M., Grasso G., and Fiordaliso F. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor Proc Natl Acad Sci U S A 101 2004 14907 14912
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 14907-14912
-
-
Brines, M.1
Grasso, G.2
Fiordaliso, F.3
-
40
-
-
0041659121
-
Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway
-
Tramontano A.F., Muniyappa R., and Black A.D. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway Biochem Biophys Res Commun 308 2003 990 994
-
(2003)
Biochem Biophys Res Commun
, vol.308
, pp. 990-994
-
-
Tramontano, A.F.1
Muniyappa, R.2
Black, A.D.3
-
41
-
-
0035044085
-
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
-
Kocher A.A., Schuster M.D., and Szabolcs M.J. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat Med 7 2001 430 436
-
(2001)
Nat Med
, vol.7
, pp. 430-436
-
-
Kocher, A.A.1
Schuster, M.D.2
Szabolcs, M.J.3
-
42
-
-
0037447256
-
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
-
Calvillo L., Latini R., and Kajstura J. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A 100 2003 4802 4806
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 4802-4806
-
-
Calvillo, L.1
Latini, R.2
Kajstura, J.3
-
43
-
-
4644227714
-
Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion
-
Lipšic E., van der Meer P., and Henning R.H. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion J Cardiovasc Pharmacol 44 2004 473 479
-
(2004)
J Cardiovasc Pharmacol
, vol.44
, pp. 473-479
-
-
Lipšic, E.1
Van Der Meer, P.2
Henning, R.H.3
-
44
-
-
28844443403
-
Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: Dose response and therapeutic window
-
Moon C., Krawczyk M., and Paik D. Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window Cardiovasc Drugs Ther 19 2005 243 250
-
(2005)
Cardiovasc Drugs Ther
, vol.19
, pp. 243-250
-
-
Moon, C.1
Krawczyk, M.2
Paik, D.3
-
45
-
-
0035370037
-
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study
-
Silverberg D.S., Wexler D., and Sheps D. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 37 2001 1775 1780
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 1775-1780
-
-
Silverberg, D.S.1
Wexler, D.2
Sheps, D.3
-
46
-
-
33845216454
-
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia
-
Palazzuoli A., Silverberg D., and Iovine F. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia Am Heart J 152 2006 1096.e9 1096.e15
-
(2006)
Am Heart J
, vol.152
-
-
Palazzuoli, A.1
Silverberg, D.2
Iovine, F.3
-
47
-
-
33745025709
-
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study
-
Lipsic E., van der Meer P., and Voors A.A. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study Cardiovasc Drugs Ther 20 2006 135 141
-
(2006)
Cardiovasc Drugs Ther
, vol.20
, pp. 135-141
-
-
Lipsic, E.1
Van Der Meer, P.2
Voors, A.A.3
-
48
-
-
77954777322
-
High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study
-
Ferrario M., Arbustini E., and Massa M. High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study Int J Cardiol 2009 [Epub ahead of print]
-
(2009)
Int J Cardiol
-
-
Ferrario, M.1
Arbustini, E.2
Massa, M.3
-
49
-
-
70349492321
-
Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction
-
Binbrek A.S., Rao N.S., and Al Khaja N. Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction Am J Cardiol 104 2009 1035 1040
-
(2009)
Am J Cardiol
, vol.104
, pp. 1035-1040
-
-
Binbrek, A.S.1
Rao, N.S.2
Al Khaja, N.3
-
50
-
-
52449091879
-
Erythropoietin in cardioprotection: Does it have a future or is it all in the past?
-
Mehta J.L. Erythropoietin in cardioprotection: does it have a future or is it all in the past? Cardiovasc Res 79 2008 549 550
-
(2008)
Cardiovasc Res
, vol.79
, pp. 549-550
-
-
Mehta, J.L.1
-
51
-
-
77958518157
-
A single dose of erythropoietin in ST-elevation myocardial infarction
-
Voors A.A., Belonje A.M., and Zijlstra F. A single dose of erythropoietin in ST-elevation myocardial infarction Eur Heart J 2010 Epub ahead of print]. DOI: 10.1093/eurheartj/ehq304
-
(2010)
Eur Heart J
-
-
Voors, A.A.1
Belonje, A.M.2
Zijlstra, F.3
-
52
-
-
43049157887
-
New limits advised for anemia drugs
-
Mitka M. New limits advised for anemia drugs JAMA 299 2008 2016
-
(2008)
JAMA
, vol.299
, pp. 2016
-
-
Mitka, M.1
-
54
-
-
33846249198
-
Rapid detection of myocardial infarction by sub-second, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance
-
Sievers B., Elliott M.D., and Hurwitz L.M. Rapid detection of myocardial infarction by sub-second, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance Circulation 115 2007 236 244
-
(2007)
Circulation
, vol.115
, pp. 236-244
-
-
Sievers, B.1
Elliott, M.D.2
Hurwitz, L.M.3
-
55
-
-
45849153884
-
Detection of left ventricular thrombus by delayed-enhancement CMR: Prevalence and markers in patients with systolic dysfunction
-
Weinsaft J.W., Kim H.W., and Shah D. Detection of left ventricular thrombus by delayed-enhancement CMR: Prevalence and markers in patients with systolic dysfunction J Am Coll Cardiol 52 2008 148 157
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 148-157
-
-
Weinsaft, J.W.1
Kim, H.W.2
Shah, D.3
-
56
-
-
7544232702
-
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
-
Pennell D.J., Sechtem U.P., and Higgins C.B. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur Heart J 25 2004 1940 1965
-
(2004)
Eur Heart J
, vol.25
, pp. 1940-1965
-
-
Pennell, D.J.1
Sechtem, U.P.2
Higgins, C.B.3
-
57
-
-
85051643203
-
Magnetic resonance imaging of the heart
-
Kim H.W., Farzaneh-Far A., and Klem I. Magnetic resonance imaging of the heart V. Fuster, R.A. O'Rourke, P. Poole-Wilson, Hurst's The Heart 13th ed. 2010 McGraw Hill New York (N.Y.)
-
(2010)
Hurst's the Heart
-
-
Kim, H.W.1
Farzaneh-Far, A.2
Klem, I.3
-
58
-
-
0033539584
-
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
-
Kim R.J., Fieno D.S., and Parrish T.B. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
-
(1999)
Circulation
, vol.100
, pp. 1992-2002
-
-
Kim, R.J.1
Fieno, D.S.2
Parrish, T.B.3
-
59
-
-
72749099997
-
Cardiovascular magnetic resonance in patients with myocardial infarction - Current and emerging applications
-
Kim H.W., Farzaneh-Far A., and Kim R.J. Cardiovascular magnetic resonance in patients with myocardial infarction - current and emerging applications J Am Coll Cardiol 55 2010 1 16
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1-16
-
-
Kim, H.W.1
Farzaneh-Far, A.2
Kim, R.J.3
|